1. Summary Information

 

 

Country

India

Company Name

SAMARTH PHARMA PRIVATE LIMITED

Principal Name 1

Mr. Kanjibhai Parmar

Status

Satisfactory

Principal Name 2

Mr. Chittozi Radhakrishnan

 

 

Registration #

11-110616

Street Address

Ram Mandir Road, Goregaon (West), Mumbai – 400 104, Maharashtra

Established Date

11.09.1997

SIC Code

--

Telephone#

91-22-66959186 / 28731021 / 28727930 / 26763735/ 3634

Business Style 1

Manufacturer

Fax #

91-22-66959185 / 28724234

Business Style 2

Exporter

Homepage

www.samarthpharma.com

Product Name 1

Cardiovascular Drugs

# of employees

60 (Approximately)

Product Name 2

Anti-neoplastic

Paid up capital

Rs. 2,500,000/-

Product Name 3

Anti-muscarinic agent

Shareholders

Directors or relatives of Directors (100%)

Banking

State Bank of India

Public Limited Corp.

NO

Business Period

15 Years

IPO

NO

International Ins.

-

Public Enterprise

NO

Rating

Ba (48)

Related Company

Relation

Country

Company Name

CEO

 

 

 

--

Note

-

 

2. Summary Financial Statement

Balance Sheet as of

31.03.2012

(Unit: Indian Rs.)

Assets

Liabilities

Current Assets

37,223,000

Current Liabilities

26,062,000

Inventories

26,664,000

Long-term Liabilities

0,000

Fixed Assets

144,482,000

Other Liabilities

11,199,000

Deferred Assets

0,000

Total Liabilities

37,261,000

Invest& other Assets

22,448,000

Retained Earnings

191,056,000

 

 

Net Worth

193,556,000

Total Assets

230,817,000

Total Liab. & Equity

230,817,000

 Total Assets

(Previous Year)

190,990,000

 

 

P/L Statement as of

31.03.2012

(Unit: Indian Rs.)

Sales

98,704,000

Net Profit

16,562,000

Sales(Previous yr)

74,790,000

Net Profit(Prev.yr)

6,779,000

 

MIRA INFORM REPORT

 

 

Report Date :

08.11.2012

 

IDENTIFICATION DETAILS

 

Name :

SAMARTH PHARMA PRIVATE LIMITED

 

 

Registered Office :

Ram Mandir Road, Goregaon (West), Mumbai – 400 104, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2012

 

 

Date of Incorporation :

11.09.1997

 

 

Com. Reg. No.:

11-110616

 

 

Capital Investment / Paid-up Capital :

Rs.2.500 Millions

 

 

CIN No.:

[Company Identification No.]

U99999MH1997PTC110616

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUMS23813G

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer, Exporter and Importer of Pharmaceutical Products.

 

 

No. of Employees :

60 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (48)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 770000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually Correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having satisfactory track. Trade relations are reported as fair. Business is active. Payments are reported to be usually correct and as per commitments.

 

The company can be considered normal for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – June 30, 2012

 

Country Name

Previous Rating

(31.03.2012)

Current Rating

(30.06.2012)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

India is developing into an open-market economy, yet traces of its past autarkic policies remain. Economic liberalization, including industrial deregulation, privatization of state-owned enterprises, and reduced controls on foreign trade and investment, began in the early 1990s and has served to accelerate the country's growth, which has averaged more than 7% per year since 1997. India's diverse economy encompasses traditional village farming, modern agriculture, handicrafts, a wide range of modern industries, and a multitude of services. Slightly more than half of the work force is in agriculture, but services are the major source of economic growth, accounting for more than half of India's output, with only one-third of its labor force. India has capitalized on its large educated English-speaking population to become a major exporter of information technology services and software workers. In 2010, the Indian economy rebounded robustly from the global financial crisis - in large part because of strong domestic demand - and growth exceeded 8% year-on-year in real terms. However, India's economic growth in 2011 slowed because of persistently high inflation and interest rates and little progress on economic reforms. High international crude prices have exacerbated the government's fuel subsidy expenditures contributing to a higher fiscal deficit, and a worsening current account deficit. Little economic reform took place in 2011 largely due to corruption scandals that have slowed legislative work. India's medium-term growth outlook is positive due to a young population and corresponding low dependency ratio, healthy savings and investment rates, and increasing integration into the global economy. India has many long-term challenges that it has not yet fully addressed, including widespread poverty, inadequate physical and social infrastructure, limited non-agricultural employment opportunities, scarce access to quality basic and higher education, and accommodating rural-to-urban migration.

Source : CIA

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

LOCATIONS

 

Registered Office :

Ram Mandir Road, Goregaon (West), Mumbai – 400 104, Maharashtra, India

Tel. No.:

91-22-66959186 / 28731021 / 28727930 / 26763735/ 3634

Fax No.:

91-22-66959185 / 28724234

E-Mail :

info@samarthpharma.com

samarth@samarthpharma.com

sales@samarthpharma.com

Website:

www.samarthpharma.com

Area :

1500 Sq. ft.

Location :

Rented

 

 

DIRECTORS

 

As on 29.09.2012

 

Name :

Mr. Kanjibhai Kalidas Parmar

Designation :

Director

Address :

10, Bhukhannan Sitaram Chawl, Janu Compound, Malad (East), Mumbai, Maharashtra, India

Date of Birth/Age :

02.05.1958

Qualification :

Graduate

Date of Appointment :

14.06.2004

DIN No.:

00172600

 

Other Directorship:

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U99999MH1997PTC110616

SAMARTH PHARMA PRIVATE LIMITED

Director

14/06/2004

14/06/2004

Active

NO

2

U65990MH1997PTC105511

SAMARTH LIFE SCIENCES PRIVATE LIMITED

Director

01/02/2006

01/02/2006

Active

NO

 

 

Name :

Mr. Chittozi Radhakrishnan

Designation :

Director

Address :

F-003, Geeta Nagar, Phase-Ill, Mira Road, Mumbai – 401 107, Maharashtra, India

Date of Birth/Age :

01.06.1952

Qualification :

Graduate

Date of Appointment :

11.09.1997

DIN No.:

02215540

 

Other Directorship:

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U99999MH1997PTC110616

SAMARTH PHARMA PRIVATE LIMITED

Director

11/09/1997

11/09/1997

Active

NO

2

U65990MH1997PTC105511

SAMARTH LIFE SCIENCES PRIVATE LIMITED

Director

01/02/2006

01/02/2006

Active

NO

3

AAA-0493

SAMARTH BIOLOGICALS LLP

Body corporate as Designated Partner

17/12/2009

17/12/2009

Active

NO

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 29.09.2012

 

Names of Shareholders

 

No. of Shares

 

Chittozi Radhakrishnan

 

300

Pranav Shah

 

74000

Rajiv Shah

 

74000

Sohini Shah

 

52300

Gunvantlal Shah

 

49400

Total

 

250000

 

Equity Share Break up (Percentage of Total Equity)

 

As on 29.09.2012

 

Category

Percentage

Directors or relatives of Directors

100.00

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer, Exporter and Importer of Pharmaceutical Products.

 

 

Products :

  • Cardiovascular Drugs
  • Anti-neoplastic
  • Anti-muscarinic agent
  • Diagnostic agents
  • Laxative
  • Anti-inflammatory analgesic antipyretic
  • Antacid antispasmodic ulcer healing drug
  • Sclerosants
  • Anthelmintic
  • Antibiotics / anti-microbials / quinolones  
  • Mucolytic agent
  • Anti-tuberculosis
  • Antidotes to poisoning
  • Nephrology drug
  • Anxiolytic and anti - convulsant
  • Anti-cold
  • Psychotropic drugs and sedative
  • Haemostatic agent
  • Antibiotics and cephalosporins
  • Anti-asthmatic

 

 

GENERAL INFORMATION

 

No. of Employees :

60 (Approximately)

 

 

Bankers :

·         State Bank of India, Jogeshwari (West) Branch, Mumbai, Maharashtra, India

·         HDFC Bank, Goregaon (West) Branch, Mumbai, Maharashtra, India 

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Satish Soni and Company

Chartered Accountants

Address :

15/ 1, 2nd Floor , Metro House, Colaba, Mumbai-400 001, Maharashtra, India

Tel. No.:

91-22-32903287

Mobile No.:

91-9322693989

Fax No.:

91-22-22876467

E-Mail :

scsoni@gmail.com

PAN.:

AAHPS3881N

 

 

CAPITAL STRUCTURE

 

As on 31.03.2012

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

250000

Equity Shares

Rs.10/- each

Rs.2.500 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

250000

Equity Shares

Rs.10/- each

Rs.2.500 Millions

 

 

 

 

 

Notes:

 

The Company has only one class of shares referred to as equity shares having a par value of Rs. 10/-. Each holder of equity shares is entitled to one vote per share.

 

The reconciliation of the number of shares outstanding and the amount of share capital is set out below:

 

Particulars

As at 31 March, 2012

 

No. of Shares

Rs. In Millions

Number of shares at the beginning

250,000

2.500

Add: Shares issued during the year as Fresh Issue

-

-

Number of shares at the end

250,000

2.500

 

Details of shares held by each shareholder holding more than 5% shares:

 

Name of Shareholders

As at 31 March, 2012

 

No. of Shares

% held

C Radhakrishnan

300

0%

Pranav Shah

74,000

30%

Rajiv Shah

74,000

30%

Sohini Shah

52,300

21%

Guvantlal Shah

49,400

20%

Number of shares at the end

250,000

100%

 

 

 

 

 

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2012

31.03.2011

31.03.2010

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

2.500

2.500

2.500

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

191.056

174.495

167.716

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

193.556

176.995

170.216

LOAN FUNDS

 

 

 

1] Secured Loans

0.000

0.000

0.000

2] Unsecured Loans

0.000

0.000

0.000

TOTAL BORROWING

0.000

0.000

0.000

DEFERRED TAX LIABILITIES

2.876

1.052

0.061

 

 

 

 

TOTAL

196.432

178.047

170.277

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

144.482

50.197

17.023

Capital work-in-progress

0.000

64.344

0.000

 

 

 

 

INVESTMENT

22.448

35.081

132.874

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

26.664
12.948
6.088

 

Sundry Debtors

17.442
11.955
6.092

 

Cash & Bank Balances

3.991
7.062
9.773

 

Other Current Assets

0.000
0.000
0.000

 

Loans & Advances

15.790
9.403
8.230

Total Current Assets

63.887
41.368

30.183

Less : CURRENT LIABILITIES & PROVISIONS

 
 

 

 

Sundry Creditors

11.345
4.898
4.830

 

Other Current Liabilities

14.717
0.200

0.000

 

Provisions

8.323
7.845

4.973

Total Current Liabilities

34.385
12.943

9.803

Net Current Assets

29.502
28.425
20.380

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.000

 

 

 

 

TOTAL

196.432

178.047

170.277

 

 

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2012

31.03.2011

31.03.2010

 

SALES

 

 

 

 

 

Income

98.704

74.790

55.483

 

 

Other Income

1.878

4.770

 

 

 

TOTAL                                    

100.582

79.560

55.483

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of Material Consumed

18.614

16.639

45.227

 

 

Purchase of Traded Goods

31.954

33.572

 

 

 

Changes in inventories of stock-in-trade

(5.567)

(2.921)

 

 

 

Employee benefits expense

8.299

6.090

 

 

 

Other expenses

16.431

13.464

 

 

 

TOTAL                                    

69.731

66.844

45.227

(Including Depreciation)

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION

30.851

12.716

 

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                    

7.323

3.658

 

 

 

 

 

 

 

PROFIT BEFORE TAX

23.528

9.058

10.256

 

 

 

 

 

Less

TAX                                                                 

6.966

2.279

1.025

 

 

 

 

 

 

PROFIT AFTER TAX

16.562

6.779

9.231

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export Earnings

0.010

1.344

NA

 

TOTAL EARNINGS

0.010

1.344

NA

 

 

 

 

 

 

Earnings Per Share (Rs.)

66.25

27.11

NA

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2012

31.03.2011

31.03.2010

PAT / Total Income

(%)

16.47
8.52

16.64

 

 

 
 

 

Net Profit Margin

(PBT/Sales)

(%)

23.84

12.11

NA

 

 

 
 

 

Return on Total Assets

(PBT/Total Assets}

(%)

11.29
9.89
21.72

 

 

 
 
 

Return on Investment (ROI)

(PBT/Networth)

 

0.12
0.05
0.06

 

 

 
 
 

Debt Equity Ratio

(Total Liability/Networth)

 

0.18
0.07
0.05

 

 

 
 
 

Current Ratio

(Current Asset/Current Liability)

 

1.86
3.20
3.07

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

Yes

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

Yes

9]

Name of person contacted

No

10]

Designation of contact person

No

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

--

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

No

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

--

22]

Litigations that the firm / promoter involved in

--

23]

Banking Details

Yes

24]

Banking facility details

No

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

FINANCIAL RESULTS

 

The Profit and Loss Account of the company shows a Net Profit amounting to Rs. 16.562 Millions.

 

GENERAL REVIEW

 

The company’s performance was satisfactory during the year. The Directors are hopeful that the company shall be able to achieve its target of Net Profit in the year to come. The future of the company seems to be bright.

 

FIXED ASSETS

 

  • Plant and Machinery
  • Factory Building
  • Godown
  • Office Building
  • Furniture and Fixture
  • Office Equipments
  • Car
  • Computer and Printer
  • Khopoli Factory
  • Khopoli Factory Land

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.54.25

UK Pound

1

Rs.87.00

Euro

1

Rs.69.83

 

INFORMATION DETAILS

 

Report Prepared by :

BSN

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILIRY

1~10

6

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

6

--CREDIT LINES

1~10

5

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

NO

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

48

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.